Medicinal Chemistry Support Program for Therapeutic Tender

• Country: USA
• Summary: Medicinal Chemistry Support Program for Therapeutic Development
• UST Ref No: 141704750
• Deadline: 04 Jun 2026
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: HHSN271201800001ISB
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• INTRODUCTION
  PURSUANT TO RFO 5.101 — PRESOLICITATION NOTICE, THIS IS A NOTICE OF A PROPOSED CONTRACT ACTION.
  THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE MODIFICATION UNDER CONTRACT NO. HHSN271201800001I WITH CURIA GLOBAL, INC.
  The National Institute on Neurological Disorders and Stroke (NINDS) and the NIH Blueprint Neurotherapeutics Network (BPN) at the National Institutes of Health (NIH) intends to modify the Single Award Indefinite Delivery, Indefinite Quantity (IDIQ) Contract No. HHSN271201800001I “Medicinal Chemistry Support Program for Therapeutic Development” to increase the Single Award IDIQ maximum by $30,145,159 from $39,500,000 to $69,645,159 during the ten (10) year ordering period from March 16, 2018 to March 15, 2028; there are no other changes.
  The increase to the IDIQ maximum will allow for the continuation of work begun under the Medicinal Chemistry Support Program for Therapeutic Development contract and prevent any delays or disruption of support services for scientific research working for the development of therapeutics essential for ongoing and upcoming pre-clinical and clinical trials while a new contract is properly planned and competed. The results of the efforts of this contract are the basis to advance preclinical candidate compounds for further development i.e., advanced PK and toxicological evaluation in preparation of IND filings. The ultimate goal of the NIH programs served by this contract and of individual projects is to bring new drugs to market. The increase in the IDIQ maximum will, therefore, allow for the continuation of work initiated under this contract.
  NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE
  The intended procurement is classified under NAICS code 541715 with a small business size standard of 1,000 employees
  REGULATORY AUTHORITY
  The resultant modification will include all applicable provisions and clauses of the Revolutionary FAR Overhaul (RFO) Initiative, in accordance with ...
• Documents:

 Tender Notice